Abstract
The in vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium africanum, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae (M. chelonei) to ticarcillin in combination with calvulanic acid (CA) was studied by the agar dilution method. All the M. tuberculosis, M. bovis, and M. africanum strains were inhibited at a ticarcillin concentration of 32 micrograms/ml or lower in combination with 5 micrograms of CA. M. chelonae and M. avium strains proved resistant to more than 128 micrograms of ticarcillin plus 5 micrograms of CA per ml. M. fortuitum strains needed 128 micrograms of ticarcillin plus 5 micrograms of CA to inhibit approximately 30% of the isolates.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bennett S., Wise R., Weston D., Dent J. Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid. Antimicrob Agents Chemother. 1983 Jun;23(6):831–834. doi: 10.1128/aac.23.6.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Ticarcillin: a review of its pharmacological properties and therapeutic efficacy. Drugs. 1980 Nov;20(5):325–352. doi: 10.2165/00003495-198020050-00001. [DOI] [PubMed] [Google Scholar]
- Casal M. J., Rodriguez F. C., Benavente M. C. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole. Antimicrob Agents Chemother. 1985 Feb;27(2):282–283. doi: 10.1128/aac.27.2.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Casal M., Rodriguez F., Benavente M., Luna M. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin. Eur J Clin Microbiol. 1986 Aug;5(4):453–454. doi: 10.1007/BF02075706. [DOI] [PubMed] [Google Scholar]
- Cynamon M. H., Palmer G. S. In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1983 Sep;24(3):429–431. doi: 10.1128/aac.24.3.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cynamon M. H., Palmer G. S. In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid. Antimicrob Agents Chemother. 1983 Jun;23(6):935–937. doi: 10.1128/aac.23.6.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- File T. M., Jr, Tan J. S., Salstrom S. J., Johnson L. A., Douglas G. F. Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections. Antimicrob Agents Chemother. 1984 Sep;26(3):310–313. doi: 10.1128/aac.26.3.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuchs P. C., Barry A. L., Thornsberry C., Jones R. N. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates. Antimicrob Agents Chemother. 1984 Mar;25(3):392–394. doi: 10.1128/aac.25.3.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neu H. C. Carbenicillin and ticarcillin. Med Clin North Am. 1982 Jan;66(1):61–77. doi: 10.1016/s0025-7125(16)31442-0. [DOI] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Dalovisio J. R., Pankey G. A. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother. 1979 Nov;16(5):611–614. doi: 10.1128/aac.16.5.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Welch D. F., Kelly M. T. Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother. 1979 Jun;15(6):754–757. doi: 10.1128/aac.15.6.754. [DOI] [PMC free article] [PubMed] [Google Scholar]